HER2 testing of multifocal invasive breast carcinoma: how many blocks are enough?
Am J Clin Pathol
; 140(4): 588-92, 2013 Oct.
Article
em En
| MEDLINE
| ID: mdl-24045558
OBJECTIVES: To determine the diagnostic yield of testing multiple blocks for HER2 in cases of multifocal breast carcinoma. METHODS: We identified 246 consecutive cases of multifocal invasive breast carcinoma in which HER2 was tested on more than 1 tumor focus. We performed an audit of all cases with respect to tumor size, grade, and histologic type. RESULTS: HER2 status was concordant between multiple foci in 230 (93.5%) of 246 cases, with the largest focus having the most positive HER2 result in 242 (98.4%) of 246 cases. We did not find a single case in which a smaller focus demonstrated a more positive HER2 status unless this focus was either higher grade or different histologically. CONCLUSIONS: Our findings support the evaluation of HER2 on the largest focus, with additional testing on smaller foci having a different histologic type or higher grade.
Palavras-chave
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Manejo de Espécimes
/
Neoplasias da Mama
/
Carcinoma Ductal de Mama
/
Receptor ErbB-2
Idioma:
En
Ano de publicação:
2013
Tipo de documento:
Article